mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.9 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |